Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Complex therapy is more effective for long-term control of scalp abscesses.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

AGEs may cause hair loss by increasing inflammation in hair follicles.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The 1927 nm fractional thulium laser effectively treats acne by targeting and improving affected skin areas.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Noninvasive scalp imaging techniques can improve patient care by reducing the need for biopsies.

Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Exosome-based therapies show promise for treating alopecia areata but need more research.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Effective treatment of folliculitis decalvans requires accurate diagnosis and more research for better therapies.

Restoring hair follicle immune privilege may help treat alopecia areata.

Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.

Follicular Unit Transplantation is an effective and safe treatment for hair loss due to scarring.